Hiroko Harashima

674 total citations
9 papers, 180 citations indexed

About

Hiroko Harashima is a scholar working on Molecular Biology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hiroko Harashima has authored 9 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Clinical Biochemistry and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hiroko Harashima's work include Mitochondrial Function and Pathology (8 papers), Metabolism and Genetic Disorders (6 papers) and RNA modifications and cancer (3 papers). Hiroko Harashima is often cited by papers focused on Mitochondrial Function and Pathology (8 papers), Metabolism and Genetic Disorders (6 papers) and RNA modifications and cancer (3 papers). Hiroko Harashima collaborates with scholars based in Japan and Australia. Hiroko Harashima's co-authors include Akira Ohtake, Kei Murayama, Yasushi Okazaki, Masakazu Kohda, Yoshihito Kishita, Yosuke Mizuno, Yukiko Yatsuka, Takuya Fushimi, Taro Yamazaki and Atsuhito Takeda and has published in prestigious journals such as Scientific Reports, The Journal of Pediatrics and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Hiroko Harashima

9 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Harashima Japan 8 158 88 32 15 8 9 180
Yukiko Yatsuka Japan 8 162 1.0× 71 0.8× 24 0.8× 11 0.7× 11 1.4× 23 182
Taro Yamazaki Japan 6 175 1.1× 136 1.5× 29 0.9× 2 0.1× 6 0.8× 11 196
J Vaquerizo Spain 5 121 0.8× 108 1.2× 23 0.7× 3 0.2× 12 152
Klaus Marquard Germany 3 73 0.5× 25 0.3× 10 0.3× 6 0.4× 8 95
Vendula Havlíčková Czechia 4 186 1.2× 80 0.9× 11 0.3× 3 0.2× 2 0.3× 6 213
Miyuki Kurata Japan 5 201 1.3× 100 1.1× 44 1.4× 9 0.6× 1 0.1× 5 246
Kateřina Hejzlarová Czechia 8 135 0.9× 56 0.6× 5 0.2× 4 0.3× 4 0.5× 9 156
Seham Alameer Saudi Arabia 8 84 0.5× 31 0.4× 21 0.7× 1 0.1× 3 0.4× 10 112
Ildikó Szatmári Hungary 6 105 0.7× 38 0.4× 21 0.7× 2 0.1× 19 145
C. Busquets Spain 7 116 0.7× 95 1.1× 15 0.5× 2 0.1× 11 160

Countries citing papers authored by Hiroko Harashima

Since Specialization
Citations

This map shows the geographic impact of Hiroko Harashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Harashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Harashima more than expected).

Fields of papers citing papers by Hiroko Harashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Harashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Harashima. The network helps show where Hiroko Harashima may publish in the future.

Co-authorship network of co-authors of Hiroko Harashima

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Harashima. A scholar is included among the top collaborators of Hiroko Harashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Harashima. Hiroko Harashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shimura, Masaru, Taro Yamazaki, Hiroko Harashima, et al.. (2021). Prenatal diagnosis of severe mitochondrial diseases caused by nuclear gene defects: a study in Japan. Scientific Reports. 11(1). 3531–3531. 1 indexed citations
2.
Kishita, Yoshihito, Masakazu Kohda, Yosuke Mizuno, et al.. (2019). Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background. International Journal of Cardiology. 279. 115–121. 33 indexed citations
3.
Borna, Nurun Nahar, Yoshihito Kishita, Masakazu Kohda, et al.. (2019). Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome. Neurogenetics. 20(1). 9–25. 44 indexed citations
4.
Kishita, Yoshihito, Masakazu Kohda, Yukiko Yatsuka, et al.. (2017). Barth Syndrome: Different Approaches to Diagnosis. The Journal of Pediatrics. 193. 256–260. 12 indexed citations
5.
Ohtake, Akira, Kei Murayama, Masayuki Mori, et al.. (2014). Diagnosis and molecular basis of mitochondrial respiratory chain disorders: Exome sequencing for disease gene identification. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(4). 1355–1359. 43 indexed citations
6.
Yamazaki, Taro, Kei Murayama, Alison G. Compton, et al.. (2013). Molecular diagnosis of mitochondrial respiratory chain disorders in Japan: Focusing on mitochondrial DNA depletion syndrome. Pediatrics International. 56(2). 180–187. 12 indexed citations
7.
Harashima, Hiroko, Kei Murayama, Takahito Wada, et al.. (2012). Two Japanese patients with Leigh syndrome caused by novel SURF1 mutations. Brain and Development. 34(10). 861–865. 10 indexed citations
8.
Sakamoto, Osamu, Toshihiro Ohura, Kei Murayama, et al.. (2011). Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the SUCLG1 gene. Pediatrics International. 53(6). 921–925. 17 indexed citations
9.
Nagasaka, Hironori, H. Kikuta, Hitoshi Chiba, et al.. (2003). Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor. European Journal of Pediatrics. 162(3). 132–138. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026